BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Al-Ahmad AJ, Pervaiz I, Karamyan VT. Neurolysin substrates bradykinin, neurotensin and substance P enhance brain microvascular permeability in a human in vitro model. J Neuroendocrinol 2021;33:e12931. [PMID: 33506602 DOI: 10.1111/jne.12931] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Wu X, Wang L, Wang K, Ke J, Li S, Meng T, Yuan H, Zhang Q, Hu F. SC79 promotes efficient entry of GDNF liposomes into brain parenchyma to repair dopamine neurons through reversible regulation of tight junction proteins. Nano Res . [DOI: 10.1007/s12274-022-4857-6] [Reference Citation Analysis]
2 Tel Adıgüzel K, Köroğlu Ö, Yaşar E, Kenan Tan A, Samur G. The relationship between dietary total antioxidant capacity, clinical parameters, and oxidative stress in fibromyalgia syndrome: A novel point of view. Turk J Phys Med Rehab 2022;68:262-270. [DOI: 10.5606/tftrd.2022.9741] [Reference Citation Analysis]
3 Gao X, Frakich N, Filippini P, Edwards LJ, Vinkemeier U, Gran B, Tanasescu R, Bayraktutan U, Colombo S, Constantinescu CS. Effects of substance P on human cerebral microvascular endothelial cell line hCMEC/D3 are mediated exclusively through a truncated NK-1 receptor and depend on cell confluence. Neuropeptides 2022. [DOI: 10.1016/j.npep.2022.102265] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Nozohouri S, Esfahani SH, Noorani B, Patel D, Villalba H, Ghanwatkar Y, Rahman MS, Zhang Y, Bickel U, Trippier PC, Karamyan VT, Abbruscato TJ. In-Vivo and Ex-Vivo Brain Uptake Studies of Peptidomimetic Neurolysin Activators in Healthy and Stroke Animals. Pharm Res 2022. [PMID: 35239135 DOI: 10.1007/s11095-022-03218-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 da Silva MF, de Araújo-Júnior JX, da Silva-Júnior EF, Heimfarth L, Martins-Filho PR, Quintans JSS, Quintans-Júnior LJ. Bradykinin-target therapies in SARS-CoV-2 infection: current evidence and perspectives. Naunyn Schmiedebergs Arch Pharmacol 2022;395:275-83. [PMID: 35089406 DOI: 10.1007/s00210-022-02206-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Rahman MS, Kumari S, Esfahani SH, Nozohouri S, Jayaraman S, Kinarivala N, Kocot J, Baez A, Farris D, Abbruscato TJ, Karamyan VT, Trippier PC. Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability. J Med Chem 2021;64:12705-22. [PMID: 34436882 DOI: 10.1021/acs.jmedchem.1c00759] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Karamyan VT. Between two storms, vasoactive peptides or bradykinin underlie severity of COVID-19? Physiol Rep 2021;9:e14796. [PMID: 33687143 DOI: 10.14814/phy2.14796] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]